We are a global, clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology an******** diseases. Our discovery an******** programs are driven by unmet medical an******** needs an******** science supporte******** our two patente******** mouse platforms for generating fully human monoclonal antibodies. We focus on developing an innovative pipeline of Next-Gen therapeutics through our internal R&D programs, collaborations with co-discovery an********-development partners an******** acquisitions. With operations in US, The Netherlands an********, we also license our core platform technology to other companies an******** institutions globally.

占位计算用